Trademark: 86822918
Status Date
Monday, January 7, 2019
Filing Date
Tuesday, November 17, 2015
Published for Opposition
Tuesday, April 12, 2016
Abandoned Date
Monday, January 7, 2019
5 Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Pharmaceutical preparations for the prevention and treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; Pharmaceutical products for the prevention and treatment of bone diseases; Pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
The wording "RHUVISE" has no meaning in a foreign language.
Jan 7, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 7, 2019
Abandonment - No Use Statement Filed
Jun 7, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 5, 2018
Extension 4 Granted
Jun 5, 2018
Extension 4 Filed
Jun 5, 2018
Teas Extension Received
Dec 5, 2017
Notice Of Approval Of Extension Request E-Mailed
Dec 3, 2017
Extension 3 Granted
Dec 3, 2017
Extension 3 Filed
Dec 3, 2017
Teas Extension Received
May 23, 2017
Notice Of Approval Of Extension Request E-Mailed
May 20, 2017
Extension 2 Granted
May 20, 2017
Extension 2 Filed
May 20, 2017
Teas Extension Received
Dec 6, 2016
Notice Of Approval Of Extension Request E-Mailed
Dec 2, 2016
Extension 1 Granted
Dec 2, 2016
Extension 1 Filed
Dec 2, 2016
Teas Extension Received
Jun 7, 2016
Noa E-Mailed - Sou Required From Applicant
Apr 12, 2016
Official Gazette Publication Confirmation E-Mailed
Apr 12, 2016
Published For Opposition
Mar 23, 2016
Notification Of Notice Of Publication E-Mailed
Mar 9, 2016
Law Office Publication Review Completed
Mar 8, 2016
Assigned To Lie
Feb 11, 2016
Approved For Pub - Principal Register
Feb 11, 2016
Examiner's Amendment Entered
Feb 11, 2016
Notification Of Examiners Amendment E-Mailed
Feb 11, 2016
Examiners Amendment E-Mailed
Feb 11, 2016
Examiners Amendment -Written
Feb 8, 2016
Assigned To Examiner
Nov 20, 2015
New Application Office Supplied Data Entered In Tram
Nov 20, 2015
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
